This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Making Affordable Care Act Patients Profitable

John Bardis, CEO, MedAssets:

I think the supply side of the business has grown pretty well, we are actually up approximately 10 percent over the prior year on the top line. But because of our leverage and the way our infrastructure functions, it creates substantial mid-teens EBITDA (earnings before interest, tax, depreciation and amortization) growth rates for us. So I think that it's a remarkable performer, but I think at this time, given that where we were a year ago, we continue to be under the microscope, Lindsey, in terms of performance. In other words, as we continue to show consistency in our performance, I think analysts on The Street will get more confidence in our ability to deliver, and quite frankly, that's what they should be focused on, challenging our ability to deliver. I think we do that, we continue to deliver better shareholder returns.

Lindsey Bell:

Okay. Great. Thank you so much for your time today.

John Bardis, CEO, MedAssets:

You too, Lindsey.
3 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
MDAS $22.25 0.41%
AAPL $112.03 2.30%
FB $93.25 0.84%
GOOG $643.48 0.68%
TSLA $220.67 -2.70%


Chart of I:DJI
DOW 17,084.49 +33.74 0.20%
S&P 500 2,013.43 +15.91 0.80%
NASDAQ 4,830.47 +19.6820 0.41%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs